379 related articles for article (PubMed ID: 34558138)
1. Apoptosis and its therapeutic implications in neurodegenerative diseases.
Erekat NS
Clin Anat; 2022 Jan; 35(1):65-78. PubMed ID: 34558138
[TBL] [Abstract][Full Text] [Related]
2. Flavonoid-based therapies in the early management of neurodegenerative diseases.
Solanki I; Parihar P; Mansuri ML; Parihar MS
Adv Nutr; 2015 Jan; 6(1):64-72. PubMed ID: 25593144
[TBL] [Abstract][Full Text] [Related]
3. Clinical potential of minocycline for neurodegenerative disorders.
Blum D; Chtarto A; Tenenbaum L; Brotchi J; Levivier M
Neurobiol Dis; 2004 Dec; 17(3):359-66. PubMed ID: 15571972
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis as a general cell death pathway in neurodegenerative diseases.
Offen D; Elkon H; Melamed E
J Neural Transm Suppl; 2000; (58):153-66. PubMed ID: 11128605
[TBL] [Abstract][Full Text] [Related]
5. Coenzyme Q treatment of neurodegenerative diseases of aging.
Galpern WR; Cudkowicz ME
Mitochondrion; 2007 Jun; 7 Suppl():S146-53. PubMed ID: 17485247
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis and caspases in neurodegenerative diseases.
Friedlander RM
N Engl J Med; 2003 Apr; 348(14):1365-75. PubMed ID: 12672865
[No Abstract] [Full Text] [Related]
7. Resveratrol: A Focus on Several Neurodegenerative Diseases.
Tellone E; Galtieri A; Russo A; Giardina B; Ficarra S
Oxid Med Cell Longev; 2015; 2015():392169. PubMed ID: 26180587
[TBL] [Abstract][Full Text] [Related]
8. Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.
Choonara YE; Pillay V; Du Toit LC; Modi G; Naidoo D; Ndesendo VMK; Sibambo SR
Int J Mol Sci; 2009 Jun; 10(6):2510-2557. PubMed ID: 19582217
[TBL] [Abstract][Full Text] [Related]
9. The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases.
Maher P
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234550
[TBL] [Abstract][Full Text] [Related]
10. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S
Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771
[TBL] [Abstract][Full Text] [Related]
11. Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases.
Wang Y; Lv MN; Zhao WJ
Ageing Res Rev; 2023 Nov; 91():102035. PubMed ID: 37619619
[TBL] [Abstract][Full Text] [Related]
12. Modulating epigenetic HAT activity for reinstating acetylation homeostasis: A promising therapeutic strategy for neurological disorders.
Ganai SA; Banday S; Farooq Z; Altaf M
Pharmacol Ther; 2016 Oct; 166():106-22. PubMed ID: 27411674
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of glutathione homeostasis in neurodegenerative diseases.
Johnson WM; Wilson-Delfosse AL; Mieyal JJ
Nutrients; 2012 Oct; 4(10):1399-440. PubMed ID: 23201762
[TBL] [Abstract][Full Text] [Related]
14. Targeting programmed cell death in neurodegenerative diseases.
Vila M; Przedborski S
Nat Rev Neurosci; 2003 May; 4(5):365-75. PubMed ID: 12728264
[No Abstract] [Full Text] [Related]
15. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
[TBL] [Abstract][Full Text] [Related]
16. Advances in Applying Computer-Aided Drug Design for Neurodegenerative Diseases.
Salman MM; Al-Obaidi Z; Kitchen P; Loreto A; Bill RM; Wade-Martins R
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925236
[TBL] [Abstract][Full Text] [Related]
17. Neurodegenerative models in Drosophila: polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis.
Ambegaokar SS; Roy B; Jackson GR
Neurobiol Dis; 2010 Oct; 40(1):29-39. PubMed ID: 20561920
[TBL] [Abstract][Full Text] [Related]
18. Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders.
Gupta R; Advani D; Yadav D; Ambasta RK; Kumar P
Mol Neurobiol; 2023 Nov; 60(11):6476-6529. PubMed ID: 37458987
[TBL] [Abstract][Full Text] [Related]
19. The potential use of tetracyclines in neurodegenerative diseases and the role of nano-based drug delivery systems.
Rahmani M; Negro Álvarez SE; Hernández EB
Eur J Pharm Sci; 2022 Aug; 175():106237. PubMed ID: 35710076
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
Aymerich MS; Aso E; Abellanas MA; Tolon RM; Ramos JA; Ferrer I; Romero J; Fernández-Ruiz J
Biochem Pharmacol; 2018 Nov; 157():67-84. PubMed ID: 30121249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
